No photos found.
Let's HOPE it is because they want to avoid any legal issues. This way, ample time has passed and retail investors have the opportunity to top up at
Interested in Day Trading and European Markets
No profile data added yet. |
No photos found.
Let's HOPE it is because they want to avoid any legal issues. This way, ample time has passed and retail investors have the opportunity to top up at
New website and looks like Ambry oncology tests now live. Looks comprehensive.
Hi Twix,Happy New Year all.Am still here and still ****ed off with what has transpired.BGF supporting and increasing stake is encouraging. As is
Absolutely. We shouldn't be here at this level to start with. £15m market cap.....madness.
I think the question we should ask ourselves are:- do we believe in the company and its product and services, and sector they are playing in? Some
Still here Twix.Poor management of share price performance.Credible execution of business plan and strategy, with room for improvement.Let's hope the
I very much see our "exit route" as being a takeover by one of the larger diagnostics businesses. For them, ebitda is not that critical. It will be
If I were Labcorp, I would just buy YGEN - can probably snap us up for $150m given our SP.Not only can they save on future royalties to Ravgen
Thanks birdie12.The recent ruling of Ravgen v Labcorp (which is subject to appeal) made we revisit the Capital Markets Day and Annual Report
Vodafone show a much smaller number. https://investors.vodafone.com/debt-investors/financing-strategy
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions